 |
인쇄하기
취소
|
KFDA likely to approve China’s new flu vaccine in October
Boryung BioPharma said that China’s first home-grown H1N1 flu vaccine, which producer Sinovac Biotech Ltd. (NYSE Amex: SVA) says is effective after only one dose, will be approved in this October at the latest, as Korea braces for a feared winter outbreak.
On September 1, Boryung signed an agreement with Sinovac to collaborate on marketing efforts and possible vaccine supply efforts to the K...
On September 1, Boryung signed an agreement with Sinovac to collaborate on marketing efforts and possible vaccine supply efforts to the K...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.